Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 828

Document Document Title
WO/2012/146914A1
Compounds which are trehalose-6-phosphate or trehalose-6-phosphonate precursors of formula (I) or agriculturally acceptable salts thereof are provided: (I) The compounds are useful in increasing starch production in plants.  
WO/2012/129651A1
The invention provides compounds of formula (I) with substituents as specified in claim 1 for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceuticals compositions including the compounds or prodrugs of the com...  
WO/2012/113404A1
The present invention relates to providing compounds of general formula (1) wherein A is glycosyl residue of a mono-, di- or oligosaccharide in protected form and R is selected from optionally substituted aryl or optionally substituted h...  
WO/2012/103990A1
The present invention relates novel phosphorainidates of monosaccharides of formula (I), wherein R1 is a monosaccharide group selected from A and B: R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16 and X are as defined h...  
WO/2012/077828A1
The purpose of the present invention is to provide a prophylactic or therapeutic agent for inflammatory diseases, which can inhibit the function of an inflammatory cytokine and therefore can exhibit an anti-inflammatory effect. The prese...  
WO/2012/073214A2
Compounds having the general formula (I) and their biological applications.  
WO/2012/025744A1
A glycodendrimer comprising: a) a non-toxic dendrimer polypropyletherimine core supporting on average in the range of 9 to 64 terminal carboxylic acid groups, and b) conjungated to said core in the range of 2 to 8 amino sugars or a sulph...  
WO/2012/025745A1
Aglycodendrimer comprising: a) a non-toxic dendrimer polypropyletherimine core supporting 16 terminal carboxylic acid groups, and b) conjungated to said core 2, 3, 4 or 5 glucosaminemolecules, wherein each glucosamineis linked directly t...  
WO/2011/039634A9
Described herein are methods and genetically engineered cells useful for uncapping a mannose- 6 -phosphate residue on an oligosaccharide by using a mannosidase capable of hydrolyzing mannose- 1 -phospho- 6 -mannose linkage to phospho - 6...  
WO/2011/069921A9
The present invention relates to an sucrose octasulfate of zinc of general formula (I), to the method for the preparation of same and to the use thereof in the pharmaceutical and/or cosmetic field, where: 0 ≤n ≤ 4, n is an integer, a...  
WO/2011/025286A2
The present invention relates to lipoteichoic acid-derived glycolipids, and to pharmaceutical, food or cosmetic compositions and vaccine adjuvants comprising same. The lipoteichoic acid-derived glycolipids according to the present invent...  
WO/2010/131712A1
Disclosed are a therapeutic pharmaceutical agent for diseases associated with the decrease in the function of GNE protein, a food composition, and a food additive. The therapeutic pharmaceutical agent is characterized by comprising a com...  
WO/2010/072977A1
The invention relates to a bacterial strain that produces enzymes having a fucanolytic activity, to a bacterial mixture containing said strain, to the use of said strain or bacterial mixture containing same for producing enzymes having a...  
WO/2010/058130A1
The invention relates to the methyl pentasaccharide O-2,3,4-tri-O-methyl-α-D-glucopyranosyl-(1 →4)-O-2,3-di-O-methyl-β-D-glucopyranosyluronic acid-(1 →4)-O-α-D-glucopyranosyl-(1 →4)-O-2,3-di-O-méthyl-α-L-idopyranosyluronic aci...  
WO/2010/051961A1
The efficient synthesis of phosphatidylinositol mono- to hexa-mannoside (PIM1 to PIM6) is reported. The invention relates to these phosphatidylinositol mono- to hexa-mannosides carrying a linker and a reactive functional group, e.g. the ...  
WO/2010/040880A1
Procedure for the synthesis of deprotected pentasaccharides from a protected precursor pentasaccharide through a reaction procedure having five stages whereamong is included an N-sulphation of amino groups and a hydrogenolysis of benzyl ...  
WO/2010/006982A1
The present invention is directed to sulfated oligosaccharides having 4, 5 or 6 saccharidic units and wherein a glycosidic bond between two saccharide units is substituted by a C-C bond, and wherein the sulfation degree expressed as perc...  
WO/2010/000013A1
The present invention relates to a sulfated polysaccharide compound and the preparation and use thereof, and in particular to a narrow distribution low molecular weight, highly sulfated pentosan (in this instance a xylan) referred to as ...  
WO/2009/143545A2
Method for sulphating pentose saccharides with diorgano-tin oxide and a sulphating agent in an organic solvent and sulphated pentose saccharides.  
WO/2009/138601A2
The invention relates to the use of mannose-6-phosphate (M6P) and of certain derivatives thereof for controlling angiogenesis and ligament regeneration and/or cartilage reconstruction. The MP6 and certain derivatives thereof can particul...  
WO/2009/138600A2
The invention relates to the use of certain derivatives of D-mannopyranoside for controlling angiogenesis. These compounds have a pro-angiogenic activity, and can particularly be used for preparing a pharmaceutical composition for treati...  
WO/2009/137899A2
The present invention relates to low molecular weight sulfated galactans, obtained from algae, particularly genus Botryocladia, preferably species Botryocladia occidentallis, which have no effect on the factor XII activation of the clott...  
WO/2009/100222A1
The present invention provides a novel liquid composition suitable for in-situ formation of a depot system to deliver a bioactive substance in a controlled manner. The composition of the present invention comprises: (a) a hydrophobic non...  
WO/2009/049370A1
The invention relates to novel compounds that have utility as inhibitors of heparan sulfate-binding proteins; compositions comprising the compounds, and use of the compounds and compositions thereof for the antiangiogenic, antimetastatic...  
WO/2009/035528A2
The invention provides functionalized monosaccharides and disaccharides suitable for use in synthesizing a lipid A derivative, as well as methods for synthesizing and using a synthetic lipid A derivative.  
WO/2009/021978A2
The invention relates to compounds of the general formula (I) where A is oxygen, sulphur or selenium, (CB)n and (CB)m are each a carbaborane or a chain of carbaboranes. R1 is selected from hydroxy, alkoxy, alkenoxy, O-glycoside, thioglyc...  
WO/2008/142155A2
The present invention concerns a method for preparing C-6 phosphorylated D- aldohexoses and C-6 phosphorylated D-aldohexose derivatives, new C-6 phosphorylated D-aldohexoses derivatives and uses thereof. The method comprises incubating p...  
WO/2008/090631A1
It is intended to provide a fucoidan-derived low molecular compound with a specified structure and function in which problems regarding absorption property, antigenicity, homogeneity, anti-coagulant activity and the like of fucoidan, whi...  
WO/2008/041131A2
The present invention is concerned with anticoagulants (i.e. substances that stop blood from clotting). More specifically, the present invention is concerned with orally available antithrombic oligosaccharides.  
WO/2008/010231A2
The present invention provides a process for the purification of Topiramate comprising treating Topiramate with aqueous alkali solution followed by washing the aqueous alkali solution of Topiramate with water immiscible solvent and neutr...  
WO/2007/132537A1
K04-0144 substances A, B and C which can be produced by culturing a microorganism exemplified by Streptomyces sp. strain K04-0144 (which is capable of producing K04-0144 substances) in a culture medium and then collecting the substances ...  
WO/2007/096532A1
The invention concerns α-D-mannopyranosyl-1 phosphate derivatives of formulae (I), (II) and (II) as medicines, wherein each R11 to R14, R21 to R24, R31 to R34 is H or a OH-protecting group, and R and R' are such as defined in the descri...  
WO/2007/083634A1
[PROBLEMS] To provide a therapeutic agent for traumatic neuropathy and/or movement disorder, particularly a therapeutic agent for traumatic neuropathy and/or movement disorder caused by spinal cord injury. [MEANS FOR SOLVING PROBLEMS] It...  
WO/2007/069603A1
The object is to isolate phosphatidylglucoside (a hysiologically active glycolipid) and an acetylated form of the glycolipid from the brain of a fetal rat, determining the structures of these compounds and evaluating the physiological ac...  
WO/2007/060692A2
The present invention relates to a compound of formula I: (A)-(L)-(B) I wherein (B) is a hydrophobic moiety; (L) is a linker which which covalently links saccharide (A) and hydrophobic moiety (B); and (A) is a saccharide which is unsubst...  
WO/2007/052308A2
The present invention relates to a compound of formula I: (I) wherein DX is a radical of a biologically active agent comprising atom X; X is selected from O and N; and A is a radical of a saccharide, or an acid, salt, or ester thereof. F...  
WO/2007/013609A1
Fucoidan is a sulfated polysaccharide having an extremely large molecular weight. In the development of pharmaceuticals and health foods using fucoidan, there are problems with respect to absorption property, antigenicity, homogeneity, a...  
WO/2006/120576A2
An oligosaccharide useful for a Meningitidis A vaccine contains a first mannose unit having a spacer in the alpha configuration at C-1, which spacer is capable of conjugating to a protein, and which is connected to a second mannose unit ...  
WO/2006/108903A1
A novel synthesis process for preparing sulphur/phosphorus (S/P) bidentate ligands from carbohydrates is described. The resulting novel compounds are thioglycoside derivatives with one anomerically positioned sulphur atom, meaning that t...  
WO/2006/097122A1
The present invention relates to ferrous fructose-1,6-diphosphate dihydrate, use, composition and a process for the obtainment thereof. The compound of the invention shows a very high Fe2+ titre and an excellent stability in time and is ...  
WO/2006/016997A2
Compounds that are adjuvants and immunoeffectors are described and claimed. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for us...  
WO/2005/095428A1
A bacterium having a functional substance on the surface; and a process for producing the bacterium. In particular, a bacterium such as, e.g., one which enhances intestinal absorption, is produced. Also provided is a compound represented...  
WO/2005/095427A1
A composition for the prevention or treatment of thrombosis, characterized by containing a compound obtained by reducing the molecular weight of a sulfated-fucose-containing polysaccharide and/or a pharmacologically acceptable salt of th...  
WO/2005/092348A1
An HGF production accelerator containing as an active ingredient an oligosaccharide which is any of a 2-saccharide comprising a uronic acid residue (the uronic acid is iduronic acid or glucuronic acid; the same applies hereinafter) and a...  
WO/2005/090382A1
The present invention relates compounds of the formula (A) oligosaccharide-spacer-GpIIb/IIIa antagonist (A), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising four to twenty five monosaccharide units,...  
WO/2005/085264A1
The invention relates to compounds which are polysufated oligosaccharide derivatives having activity as inhibitors of heparan sulfate-binding proteins and inhibitors of the enzyme heparanase; methods for the preparation of the compounds;...  
WO/2005/080490A1
The present invention relates to a solution of metal-polymer chelate(s) and applications thereof, the solution contains one kind or more kinds of metal-polymer chelate(s) , the metal-polymer chelate(s) is/are prepared as follows: a polym...  
WO/2005/075490A2
The invention provides a new synthetic method for the synthesis of pure polysulfated glycosides having well-defined chemical structures. These compounds can be synthesized by sterospecific synthesis from glucose and glucose amine, and gl...  
WO/2005/070944A1
The present invention provides a phosphoramidate compound comprising the structure (I) Formula (I)wherein: X comprises a monosaccharide group comprising the structure (II) or (III),8Formula (II) , (III) B and B are independently selected...  
WO/2005/061523A1
The invention relates to compounds that are designed to mimic the structure of GAGs; methods for the preparation of the compounds; compositions comprising the compounds; and use of the compounds and compositions thereof for the anti-angi...  

Matches 51 - 100 out of 828